Method aids glaucoma discrimination

Article

New technique improves diffrentiation between normal and glaucomatous eyes

The new technique, developed by the Glaucoma Imaging Group at the University of Pittsburgh Medical Center (UPMC) Eye Center under the direction of Dr Joel Schuman, chairman, is based on superpixel machineclassifier analysis of three-dimensional (3D) spectral-domain optical coherence tomography (SDOCT). While the faster scanning speed of SDOCT allows 3D volume scanning of the retinal layers and enhances early detection of glaucoma and monitoring of disease, these structural measurements do not take full advantage of the 3D dataset, Dr Xu noted.

Only 512 sampling points out of 40000 are used in the conventional retinal nerve fiber layer (RNFL) analysis, and signs of pathologic damage may be missed.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.